期刊文献+

Flt3配基与白血病

Flt3 ligand and leukemia
下载PDF
导出
摘要 Flt3配基(FL)是一种与造血调控有关的造血细胞生长因子,其可能与白血病的发病有一定关系,已有体外实验证实,将其作为树突状细胞(DC)的诱导剂,在肿瘤免疫治疗中能开辟一个崭新的领域。该文将FL与白血病方面的关系作一综述。 Flt3 ligand (FL) is an early acting hematopoietic cytokine. It is possible that FL has some rela- tionship with leukemia. Recently, some studies has shown that FL can be applicated for tumor immunotherapy. This paper reviews the relationship between FL and leukemia.
出处 《新医学》 2013年第3期154-156,共3页 Journal of New Medicine
关键词 FLT3配基 白血病 造血细胞因子 肿瘤免疫治疗 Flt3 ligand Leukemia Hematopoietic cytokine Tumor immunotherapy
  • 相关文献

参考文献12

  • 1Zheng R, Levis M, Piloto O, et al. FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood, 2004, 103 : 267-274.
  • 2王静,韩颖,化罗明,郭晓楠,徐世荣.Flt3/FL在急性白血病中的表达及其临床意义[J].临床荟萃,2009,24(23):2073-2075. 被引量:2
  • 3王静,化罗明,郭晓楠,徐世荣,贾存荣.Flt3配体在急性髓系白血病化疗过程中的变化及意义[J].广东医学,2012,33(17):2639-2640. 被引量:6
  • 4曹仕煜,陈永锋.FL与骨髓造血调控[J].四川解剖学杂志,2009,17(3):41-42. 被引量:3
  • 5Maraskovsky E, Daro E, Roux E, et al. In vivo genera- tion of human dendritic cells subsets by Flt3 ligand. Blood, 2000, 96 : 878-884.
  • 6Mckenna HJ. Role of hematopoietic ligand in expansion Curr Opin Hematol, and regulation growth factors/rid of dendritic cells. 2001, 8:149-54.
  • 7Curti A, Fogli M, Ratta M, et al. Stem cell factor and FLT3-1igand are strictly required to sustain the long-term expansion of primitive CD34^+ DR- dendritic cell precur- sors. J Immunol, 2001, 166: 848-854.
  • 8Gammaitoni L, Bruno S, Sanavio F, et al. Ex vivo ex- pansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol, 2003, 31: 261-270.
  • 9Kaushansky K. Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell. Ann N Y Acad Sci, 2003, 996: 39-43.
  • 10Naoe T, Kiyoi H. Normal and oncogenic FLT3. Cell Mol Life Sci, 2004, 61: 2932-2948.

二级参考文献39

  • 1Li K, Yang M, Lam AC,et al. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors, 2000,9(1) : 125-131.
  • 2Robinson S, Mosley RL, Parajuli P, et al. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macropbage colony-stimulating factor acting alone or in combination. J Hematother Stem Cell Res,2000,9(5):711-720.
  • 3Blumenthal RD, Walter L, Malik J, et al. Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy. Cancer, 2000,88(2) :333-343.
  • 4Gazitt Y, Liu Q, High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34 + PBSC in patients undergoing high-dose chemotherapy and stem cell rescue. J Hematother Stem Cell Res, 2000,9 (2) : 285-293.
  • 5Lyman SD,James L, Bos TV, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell,1993,75(6): 1157-1167.
  • 6Lyman SD,James L,Johnson L,et al. Cloning of the human homologue of the murine fit3 ligand: a growth factor for early hematopoietic progenitor cells. Blood, 1994,83(10) : 2795-2801.
  • 7Slanieka Krieger M, Nissen C, Manz CY, et al. The membranebound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietie cells in long-term cultures of normal and aplastie anemia bone marrow. Exp Hematol, 1998,26 (5):365-373.
  • 8Drexler HG,Quentmeier H. FLT3; receptor and ligand. Growth Factors. 2004, 22(2) : 71-73.
  • 9Savvides SN, Boone T, Andrew Karplus P. Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots. Nat Struct Biol. 2000;7(6) :486-491.
  • 10Papayannopoulou T, Nakarnoto B, Andrews RG, et al. In vivo effects of Flt3/Flk2 ligand on mobilization of hernatopoietic progenitors in primates and potent synergistic enhancement with granulocyte colonystimulating factor. Blood, 1997,90(2):620-629.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部